These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7473559)

  • 1. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.
    Fukami T; Nagase T; Fujita K; Hayama T; Niiyama K; Mase T; Nakajima S; Fukuroda T; Saeki T; Nishikibe M
    J Med Chem; 1995 Oct; 38(21):4309-24. PubMed ID: 7473559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
    Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.
    Ihara M; Noguchi K; Saeki T; Fukuroda T; Tsuchida S; Kimura S; Fukami T; Ishikawa K; Nishikibe M; Yano M
    Life Sci; 1992; 50(4):247-55. PubMed ID: 1310132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
    Awane-Igata Y; Ikeda S; Watanabe T
    Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic hexapeptide endothelin receptor antagonists highly potent for both receptor subtypes ETA and ETB.
    Kikuchi T; Ohtaki T; Kawata A; Imada T; Asami T; Masuda Y; Sugo T; Kusumoto K; Kubo K; Watanabe T
    Biochem Biophys Res Commun; 1994 May; 200(3):1708-12. PubMed ID: 8185629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.
    Davenport AP; O'Reilly G; Molenaar P; Maguire JJ; Kuc RE; Sharkey A; Bacon CR; Ferro A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S22-5. PubMed ID: 7509950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD; Allcock GH; Vane JR
    Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of 2-substituted D-tryptophan-containing peptidic endothelin receptor antagonists: importance of the C-2 substituent of the D-tryptophan residue for endothelin A and B receptor subtype selectivity.
    Fukami T; Yamakawa T; Niiyama K; Kojima H; Amano Y; Kanda F; Ozaki S; Fukuroda T; Ihara M; Yano M; Ishikawa K
    J Med Chem; 1996 Jun; 39(12):2313-30. PubMed ID: 8691426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid peptides constructed from RES-701-1, an endothelin B receptor antagonist, and endothelin; binding selectivity for endothelin receptors and their pharmacological activity.
    Shibata K; Suzawa T; Ohno T; Yamada K; Tanaka T; Tsukuda E; Matsuda Y; Yamasaki M
    Bioorg Med Chem; 1998 Dec; 6(12):2459-67. PubMed ID: 9925302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies with a series of hexapeptide endothelin antagonists.
    Doherty AM; Cody WL; He JX; DePue PL; Cheng XM; Welch KM; Flynn MA; Reynolds EE; LaDouceur DM; Davis LS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S98-102. PubMed ID: 7510009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.
    Kikuchi T; Kubo K; Ohtaki T; Suzuki N; Asami T; Shimamoto N; Wakimasu M; Fujino M
    J Med Chem; 1993 Dec; 36(25):4087-93. PubMed ID: 8258832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of endothelinA (ETA) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction.
    Goldie RG; Grayson PS; Knott PG; Self GJ; Henry PJ
    Br J Pharmacol; 1994 Jul; 112(3):749-56. PubMed ID: 7921598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction.
    LaDouceur DM; Flynn MA; Keiser JA; Reynolds E; Haleen SJ
    Biochem Biophys Res Commun; 1993 Oct; 196(1):209-15. PubMed ID: 8216294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.
    Henry PJ
    Br J Pharmacol; 1993 Sep; 110(1):435-41. PubMed ID: 8220905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of two novel mixed ETA/ETB receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit.
    Maurice MC; Gratton JP; D'Orléans-Juste P
    Br J Pharmacol; 1997 Jan; 120(2):319-25. PubMed ID: 9117126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency of PD155080, an orally active ETA receptor antagonist, determined for human endothelin receptors.
    Maguire JJ; Kuc RE; Doherty AM; Davenport AP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S362-4. PubMed ID: 8587415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin receptors in human coronary artery and aorta.
    Bacon CR; Davenport AP
    Br J Pharmacol; 1996 Mar; 117(5):986-92. PubMed ID: 8851522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.